Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol (Q28251963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

23 February 2020

main subject

1 reference

1 reference

Antonio Simone Laganà

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Luisa Barbaro

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alfonsa Pizzo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

22 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

Archives of Gynecology and Obstetrics

23 February 2020

published in

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

1181-1186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00404-014-3552-6

23 February 2020

exact match

0 references

cites work

The prevalence and features of the polycystic ovary syndrome in an unselected population

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Polycystic ovary syndrome: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Androgen excess is the key element in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Insulin and hyperandrogenism in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Myo-inositol may prevent gestational diabetes in PCOS women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Cohort studies: marching towards outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Phosphoinositides in cell regulation and membrane dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Does ovary need D-chiro-inositol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3552-6

10.1007/S00404-014-3552-6

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3475641

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 February 2020

1003948631

0 references

3475641

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3475641

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416201%20AND%20SRC:MED&resulttype=core&format=json